Cargando…

Infections in neutropenic patients I: Aetiology

Improvement in supportive care including the introduction of new antibiotics, antiviral and antifungal agents and haematopoietic growth factors have all contributed to a decreased chemotherapy-related mortality and morbidity in cancer patients. However, infections/septic shock during neutropenia sti...

Descripción completa

Detalles Bibliográficos
Autores principales: Engervall, Per, Björkholm, Magnus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Humana Press 1995
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101772/
https://www.ncbi.nlm.nih.gov/pubmed/8832528
http://dx.doi.org/10.1007/BF02990570
_version_ 1783511692885360640
author Engervall, Per
Björkholm, Magnus
author_facet Engervall, Per
Björkholm, Magnus
author_sort Engervall, Per
collection PubMed
description Improvement in supportive care including the introduction of new antibiotics, antiviral and antifungal agents and haematopoietic growth factors have all contributed to a decreased chemotherapy-related mortality and morbidity in cancer patients. However, infections/septic shock during neutropenia still constitutes a major threat to these patients. Most patients develop fever during neutropenia and in 20–40% a manifest bacteremia is documented. In patients with prolonged neutropenia, the risk for fungal infections is increased. The spectrum of bacterial, fungal and viral infections in the neutropenic patient is reviewed.
format Online
Article
Text
id pubmed-7101772
institution National Center for Biotechnology Information
language English
publishDate 1995
publisher Humana Press
record_format MEDLINE/PubMed
spelling pubmed-71017722020-03-31 Infections in neutropenic patients I: Aetiology Engervall, Per Björkholm, Magnus Med Oncol Review Improvement in supportive care including the introduction of new antibiotics, antiviral and antifungal agents and haematopoietic growth factors have all contributed to a decreased chemotherapy-related mortality and morbidity in cancer patients. However, infections/septic shock during neutropenia still constitutes a major threat to these patients. Most patients develop fever during neutropenia and in 20–40% a manifest bacteremia is documented. In patients with prolonged neutropenia, the risk for fungal infections is increased. The spectrum of bacterial, fungal and viral infections in the neutropenic patient is reviewed. Humana Press 1995 /pmc/articles/PMC7101772/ /pubmed/8832528 http://dx.doi.org/10.1007/BF02990570 Text en © Chapman & Hall 1995 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Review
Engervall, Per
Björkholm, Magnus
Infections in neutropenic patients I: Aetiology
title Infections in neutropenic patients I: Aetiology
title_full Infections in neutropenic patients I: Aetiology
title_fullStr Infections in neutropenic patients I: Aetiology
title_full_unstemmed Infections in neutropenic patients I: Aetiology
title_short Infections in neutropenic patients I: Aetiology
title_sort infections in neutropenic patients i: aetiology
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101772/
https://www.ncbi.nlm.nih.gov/pubmed/8832528
http://dx.doi.org/10.1007/BF02990570
work_keys_str_mv AT engervallper infectionsinneutropenicpatientsiaetiology
AT bjorkholmmagnus infectionsinneutropenicpatientsiaetiology